Dluzen Douglas F, Sutliff Aimee K, Chen Gang, Watson Christy J W, Ishmael Faoud T, Lazarus Philip
National Institute on Aging, National Institutes of Health, Baltimore, Maryland (D.F.D.); Department of Pulmonary Medicine, Penn State University College of Medicine, Hershey, Pennsylvania (F.T.I.); and Department of Pharmaceutical Sciences, Washington State University College of Pharmacy, Spokane, Washington (A.K.S., G.C., C.W., P.L.).
National Institute on Aging, National Institutes of Health, Baltimore, Maryland (D.F.D.); Department of Pulmonary Medicine, Penn State University College of Medicine, Hershey, Pennsylvania (F.T.I.); and Department of Pharmaceutical Sciences, Washington State University College of Pharmacy, Spokane, Washington (A.K.S., G.C., C.W., P.L.)
J Pharmacol Exp Ther. 2016 Oct;359(1):182-93. doi: 10.1124/jpet.116.235044. Epub 2016 Jul 29.
The UDP-glucuronosyltransferase (UGT) 2B enzymes are important in the detoxification of a variety of endogenous and exogenous compounds, including many hormones, drugs, and carcinogens. Identifying novel mechanisms governing their expression is important in understanding patient-specific response to drugs and cancer risk factors. In silico prediction algorithm programs were used to screen for microRNAs (miRNAs) as potential regulators of UGT2B enzymes, with miR-216b-5p identified as a potential candidate. Luciferase data suggested the presence of a functional miR-216b-5p binding motif within the 3' untranslated regions of UGTs 2B7, 2B4, and 2B10. Overexpression of miR-216b-5p mimics significantly repressed UGT2B7 (P < 0.001) and UGT2B10 (P = 0.0018) mRNA levels in HuH-7 cells and UGT2B4 (P < 0.001) and UGT2B10 (P = 0.018) mRNA in Hep3B cells. UGT2B7 protein levels were repressed in both HuH-7 and Hep3B cells in the presence of increasing miR-216b-5p concentrations, corresponding with significant (P < 0.001 and P = 0.011, respectively) decreases in glucuronidation activity against the UGT2B7-specific substrate epirubicin. Inhibition of endogenous miR-216b-5p levels significantly increased UGT2B7 mRNA levels in HuH-7 (P = 0.021) and Hep3B (P = 0.0068) cells, and increased epirubicin glucuronidation by 85% (P = 0.057) and 50% (P = 0.012) for HuH-7 and Hep3B cells, respectively. UGT2B4 activity against codeine and UGT2B10 activity against nicotine were significantly decreased in both HuH-7 and Hep3B cells (P < 0.001 and P = 0.0048, and P = 0.017 and P = 0.043, respectively) after overexpression of miR-216b-5p mimic. This is the first evidence that miRNAs regulate UGT 2B7, 2B4, and 2B10 expression, and that miR-216b-5p regulation of UGT2B proteins may be important in regulating the metabolism of UGT2B substrates.
UDP-葡萄糖醛酸基转移酶(UGT)2B家族酶在多种内源性和外源性化合物的解毒过程中发挥着重要作用,这些化合物包括许多激素、药物和致癌物。识别调控其表达的新机制,对于理解患者对药物的特异性反应以及癌症风险因素具有重要意义。利用计算机预测算法程序筛选作为UGT2B酶潜在调节因子的微小RNA(miRNA),其中miR-216b-5p被确定为一个潜在候选分子。荧光素酶数据表明,在UGT 2B7、2B4和2B10的3'非翻译区内存在一个功能性的miR-216b-5p结合基序。miR-216b-5p模拟物的过表达显著抑制了HuH-7细胞中UGT2B7(P < 0.001)和UGT2B10(P = 0.0018)的mRNA水平,以及Hep3B细胞中UGT2B4(P < 0.001)和UGT2B10(P = 0.018)的mRNA水平。在HuH-7和Hep3B细胞中,随着miR-216b-5p浓度的增加,UGT2B7蛋白水平均受到抑制,这与针对UGT2B7特异性底物表柔比星的葡萄糖醛酸化活性显著降低(分别为P < 0.001和P = 0.011)相对应。抑制内源性miR-216b-5p水平可显著提高HuH-7(P = 0.021)和Hep3B(P = 0.0068)细胞中UGT2B7的mRNA水平,并且HuH-7和Hep3B细胞中表柔比星葡萄糖醛酸化分别增加85%(P = 0.057)和50%(P = 0.012)。在过表达miR-216b-5p模拟物后,HuH-7和Hep3B细胞中UGT2B4针对可待因的活性以及UGT2B10针对尼古丁的活性均显著降低(分别为P < 0.001和P = 0.0048,以及P = 0.017和P = 0.043)。这是miRNA调节UGT 2B7、2B4和2B10表达的首个证据,并且miR-216b-5p对UGT2B蛋白的调节可能在调控UGT2B底物的代谢中具有重要作用。